keyword
https://read.qxmd.com/read/38637760/the-endothelium-gatekeeper-to-lung-ischemia-reperfusion-injury
#21
REVIEW
Huy Q Ta, Maniselvan Kuppusamy, Swapnil K Sonkusare, Mark E Roeser, Victor E Laubach
The success of lung transplantation is limited by the high rate of primary graft dysfunction due to ischemia-reperfusion injury (IRI). Lung IRI is characterized by a robust inflammatory response, lung dysfunction, endothelial barrier disruption, oxidative stress, vascular permeability, edema, and neutrophil infiltration. These events are dependent on the health of the endothelium, which is a primary target of IRI that results in pulmonary endothelial barrier dysfunction. Over the past 10 years, research has focused more on the endothelium, which is beginning to unravel the multi-factorial pathogenesis and immunologic mechanisms underlying IRI...
April 18, 2024: Respiratory Research
https://read.qxmd.com/read/38637216/outcomes-in-facial-transplantation-a-systematic-review
#22
REVIEW
Michalis Hadjiandreou, Georgios Pafitanis, Peter M Butler
Facial transplantations have become a clinical reality as the last reconstructive option in severely disfigured patients. To date, clinical outcomes remain unclear. The purpose of this paper was to analyse the outcomes in facial transplantation (FT) and determine the risks and benefits of FT based on short- and long-term outcomes. An electronic literature search was performed across PubMed, EMBASE and the Cochrane Central Register for Controlled Trials (CENTRAL) databases to capture all the relevant records relating to outcomes in FTs from 2005 to 2021...
February 28, 2024: British Journal of Oral & Maxillofacial Surgery
https://read.qxmd.com/read/38634281/resident-memory-t-cells-in-the-atherosclerotic-lesion-associate-with-reduced-macrophage-content-and-increased-lesion-stability
#23
JOURNAL ARTICLE
M J M de Jong, M A C Depuydt, F H Schaftenaar, K Liu, D Maters, Anouk Wezel, Harm J Smeets, J Kuiper, I Bot, K van Gisbergen, B Slütter
BACKGROUND: Tissue resident memory T (TRM ) cells are a T-cell subset that resides at the site of prior antigen recognition to protect the body against reoccurring encounters. Besides their protective function, TRM cells have also been implicated in inflammatory disorders. TRM cells are characterized by the expression of CD69 and transcription factors Hobit (homolog of Blimp-1 [B lymphocyte-induced maturation protein 1] in T cells) and Blimp-1. As the majority of T cells in the arterial intima expresses CD69, TRM cells may contribute to the pathogenesis of atherosclerosis as well...
April 18, 2024: Arteriosclerosis, Thrombosis, and Vascular Biology
https://read.qxmd.com/read/38633259/case-report-a-successful-clinical-experience-of-transplantation-of-liver-and-kidney-from-a-donor-with-myelodysplastic-syndromes
#24
Kang Huang, Qiuyan Zhang, Sanyun Wu, Lihua Zhou, Wenjin Liang, Xiaoyan Hu, Shaojun Ye, Wei Zhou
With a shortage of organs for transplant, the use of marginal donors can be an effective measure to meet the shortfall. Myelodysplastic syndromes (MDS) are considered an absolute contraindication for organ donation because of the high invasive potential. Currently, organ transplantation from donors with a past history of MDS has not been reported. In this paper, we report the successful clinical experience of one liver transplantation and two kidney transplantations, with organs donated by a 39-year-old patient diagnosed with a past history of MDS following intracranial hemorrhage...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38633256/detecting-t-cell-clonal-expansions-and-quantifying-clone-survival-using-deep-profiling-of-immune-repertoires
#25
JOURNAL ARTICLE
Anastasia V Pavlova, Ivan V Zvyagin, Mikhail Shugay
An individual's T-cell repertoire constantly changes under the influence of external and internal factors. Cells that do not receive a stimulatory signal die, while those that encounter and recognize a pathogen or receive a co-stimulatory signal divide, resulting in clonal expansions. T-cell clones can be traced by monitoring the presence of their unique T-cell receptor (TCR) sequence, which is assembled de novo through a process known as V(D)J rearrangement. Tracking T cells can provide valuable insights into the survival of cells after hematopoietic stem cell transplantation (HSCT) or cancer treatment response and can indicate the induction of protective immunity by vaccination...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38633119/graft-versus-host-disease-after-autologous-stem-cell-transplantation-in-a-recipient-who-underwent-allogeneic-stem-cell-transplantation-20-years-earlier
#26
JOURNAL ARTICLE
Osamu Imataki, Shunsuke Yoshida, Tomoya Ishida, Haruyuki Fujita, Makiko Uemura
A literature review does not provide information about the safety of autologous hematopoietic stem cell transplantation (HSCT) in a recipient who has previously received allogeneic HSCT. We treated a 69-year-old woman with diffuse large B cell lymphoma. The patient received autologous stem cell transplantation (ASCT) in the second complete remission of malignant lymphoma. The patient had undergone allogeneic hematopoietic SCT (allo-HSCT) for chronic myeloid leukemia 20 years ago. Chronic myeloid leukemia had been in complete remission for the previous 20 years...
April 2024: EJHaem
https://read.qxmd.com/read/38632868/the-potency-of-hematopoietic-stem-cell-reprogramming-for-changing-immune-tone
#27
REVIEW
Andrew W Daman, Jin Gyu Cheong, Laura Berneking, Steven Z Josefowicz
Innate immune memory endows innate immune cells with antigen independent heightened responsiveness to subsequent challenges. The durability of this response can be mediated by inflammation induced epigenetic and metabolic reprogramming in hematopoietic stem and progenitor cells (HSPCs) that are maintained through differentiation to mature immune progeny. Understanding the mechanisms and extent of trained immunity induction by pathogens and vaccines, such as BCG, in HSPC remains a critical area of exploration with important implications for health and disease...
April 17, 2024: Immunological Reviews
https://read.qxmd.com/read/38629074/donor-kir-genotype-based-outcome-prediction-after-allogeneic-stem-cell-transplantation-no-land-in-sight
#28
JOURNAL ARTICLE
Johannes Schetelig, Henning Baldauf, Falk Heidenreich, Jorinde D Hoogenboom, Stephen R Spellman, Alexander Kulagin, Thomas Schroeder, Henrik Sengeloev, Peter Dreger, Edouard Forcade, Jan Vydra, Eva Maria Wagner-Drouet, Goda Choi, Shankara Paneesha, Nuno A A Miranda, Alina Tanase, Liesbeth C de Wreede, Vinzenz Lange, Alexander H Schmidt, Jürgen Sauter, Joshua A Fein, Yung-Tsi Bolon, Meilun He, Steven G E Marsh, Shahinaz M Gadalla, Sophie Paczesny, Annalisa Ruggeri, Christian Chabannon, Katharina Fleischhauer
Optimizing natural killer (NK) cell alloreactivity could further improve outcome after allogeneic hematopoietic cell transplantation (alloHCT). The donor's Killer-cell Immunoglobulin-like Receptor (KIR) genotype may provide important information in this regard. In the past decade, different models have been proposed aiming at maximizing NK cell activation by activating KIR-ligand interactions or minimizing inhibitory KIR-ligand interactions. Alternative classifications intended predicting outcome after alloHCT by donor KIR-haplotypes...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38628147/metabolic-programming-of-organ-specific-natural-killer-cell-responses
#29
REVIEW
Rebecca B Delconte, Joseph C Sun
Cells of the mammalian innate immune system have evolved to protect the host from various environmental or internal insults and injuries which perturb the homeostatic state of the organism. Among the lymphocytes of the innate immune system are natural killer (NK) cells, which circulate and survey host tissues for signs of stress, including infection or transformation. NK cells rapidly eliminate damaged cells in the blood or within tissues through secretion of cytolytic machinery and production of proinflammatory cytokines...
April 17, 2024: Immunological Reviews
https://read.qxmd.com/read/38628138/innate-immunity-with-an-adaptive-twist
#30
JOURNAL ARTICLE
Steven Z Josefowicz, Joseph C Sun
No abstract text is available yet for this article.
April 17, 2024: Immunological Reviews
https://read.qxmd.com/read/38625480/design-cohort-profile-and-comparison-of-the-ktd-innov-study-a-prospective-multidimensional-biomarker-validation-study-in-kidney-allograft-rejection
#31
JOURNAL ARTICLE
Valentin Goutaudier, Marta Sablik, Maud Racapé, Olivia Rousseau, Benoit Audry, Nassim Kamar, Marc Raynaud, Olivier Aubert, Béatrice Charreau, Emmanuelle Papuchon, Richard Danger, Laurence Letertre, Lionel Couzi, Emmanuel Morelon, Moglie Le Quintrec, Jean-Luc Taupin, Eric Vicaut, Christophe Legendre, Hoa Le Mai, Vishnu Potluri, Thi-Van-Ha Nguyen, Marie-Eliane Azoury, Alice Pinheiro, Georges Nouadje, Pierre Sonigo, Dany Anglicheau, Ineke Tieken, Serge Vogelaar, Christian Jacquelinet, Peter Reese, Pierre-Antoine Gourraud, Sophie Brouard, Carmen Lefaucheur, Alexandre Loupy
There is an unmet need for robust and clinically validated biomarkers of kidney allograft rejection. Here we present the KTD-Innov study (ClinicalTrials.gov, NCT03582436), an unselected deeply phenotyped cohort of kidney transplant recipients with a holistic approach to validate the clinical utility of precision diagnostic biomarkers. In 2018-2019, we prospectively enrolled consecutive adult patients who received a kidney allograft at seven French centers and followed them for a year. We performed multimodal phenotyping at follow-up visits, by collecting clinical, biological, immunological, and histological parameters, and analyzing a panel of 147 blood, urinary and kidney tissue biomarkers...
April 16, 2024: European Journal of Epidemiology
https://read.qxmd.com/read/38625069/investigation-of-biomarkers-to-predict-outcomes-in-allogeneic-hematopoietic-stem-cell-transplantation
#32
JOURNAL ARTICLE
Takayoshi Tachibana, Takuya Miyazaki, Ayako Matsumura, Maki Hagihara, Masatsugu Tanaka, Satoshi Koyama, Eriko Ogusa, Jun Aoki, Yuki Nakajima, Hiroyuki Takahashi, Taisei Suzuki, Yoshimi Ishii, Haruka Teshigawara, Kenji Matsumoto, Mayumi Hatayama, Akihiko Izumi, Katsuya Ikuta, Koji Yamamoto, Heiwa Kanamori, Shin Fujisawa, Hideaki Nakajima
BACKGROUND: Various biomarkers have been developed and evaluated to predict the prognosis and complications of allogeneic hematopoietic cell transplantation (HCT). Most previous studies conducted on different biomarkers evaluated single effects such as those associated with inflammation, immunology, iron metabolism, and nutrition, and only a few studies have comprehensively analyzed markers. OBJECTIVE: The study aimed to survey comprehensive multiple markers prior to HCT and extract those that significantly predict the outcomes...
March 30, 2024: Cytotherapy
https://read.qxmd.com/read/38625025/a-multiplex-fluorescence-of-loop-primer-upon-self-dequenching-loop-mediated-isothermal-amplification-assay-for-the-detection-of-epstein-barr-virus-and-human-parvovirus-b19-in-clinical-transplant-samples
#33
JOURNAL ARTICLE
Yushan Xu, Miaomiao Li, Mengjiao Lin, Yan Lv, Dawei Cui, Yongjun Wang, Jue Xie
Viral infections are major causes of mortality in solid-organ and hematopoietic stem cell transplant recipients. Epstein-Barr virus (EBV) and Parvovirus B19 (B19V) are among the common viral infections after transplantation and were recommended for increased screening in relevant guidelines. Therefore, the development of rapid, specific, and cost-effective diagnostic methods for EBV and B19V is of paramount importance. We applied Fluorescence of Loop Primer Upon Self-Dequenching Loop-mediated Isothermal Amplification (FLOS-LAMP) for the first time to develop a novel multiplex assay for the detection of EBV and B19V; the fluorophore attached to the probe are self-quenched in unbound state...
April 16, 2024: Viral Immunology
https://read.qxmd.com/read/38623584/microbial-perspective-on-the-skin-gut-axis-and-atopic-dermatitis
#34
REVIEW
Bo Qu, Xue-Er Zhang, Haoyue Feng, Bonan Yan, Yingchun Bai, Shanlin Liu, Yuhua He
Atopic dermatitis (AD) is a relapsing inflammatory skin condition that has become a global health issue with complex etiology and mounting prevalence. The association of AD with skin and gut microbiota has been revealed by virtue of the continuous development of sequencing technology and genomics analysis. Also, the gut-brain-skin axis and its mutual crosstalk mechanisms have been gradually verified. Accordingly, the microbiota-skin-gut axis also plays an important role in allergic skin inflammation. Herein, we reviewed the relationship between the microbiota-skin-gut axis and AD, explored the underlying signaling molecules and potential pathways, and focused on the potential mechanisms of probiotics, antimicrobial peptides (AMPs), coagulase-negative staphylococci transplantation, fecal microbiota transplantation, AMPs, and addition of essential fatty acids in alleviating AD, with the aim to provide a new perspective for targeting microbiota in the treatment of allergic skin inflammation...
2024: Open Life Sciences
https://read.qxmd.com/read/38619272/virological-innate-and-adaptive-immune-profiles-shaped-by-variation-in-route-and-age-of-host-in-murine-cytomegalovirus-infection
#35
JOURNAL ARTICLE
Christopher P Coplen, Mladen Jergovic, Elana L Terner, Christine M Bradshaw, Jennifer L Uhrlaub, Janko Ž Nikolich
UNLABELLED: Human cytomegalovirus (hCMV) is a ubiquitous facultative pathogen, which establishes a characteristic latent and reactivating lifelong infection in immunocompetent hosts. Murine CMV (mCMV) infection is widely used as an experimental model of hCMV infection, employed to investigate the causal nature and extent of CMV's contribution to inflammatory, immunological, and health disturbances in humans. Therefore, mimicking natural human infection in mice would be advantageous to hCMV research...
April 15, 2024: Journal of Virology
https://read.qxmd.com/read/38618727/efficacy-and-nuances-of-precision-molecular-engineering-for-hodgkin-s-disease-to-a-gene-therapeutic-approach
#36
JOURNAL ARTICLE
Muhammad Imran Qadir, Bilal Ahmed, Nadir Hussain
Gene therapy is a particularly useful treatment for nervous system genetic diseases, including those induced especially by infectious organisms and antigens, and is being utilized to treat Hodgkin's disease (HD). Due to the possible clonal relationship between both disorders, immunotherapy directed against CD20 positive cells may be a more effective treatment in patients with persistent HD and NHL. HL growth can be inhibited both in vitro and in vivo by AdsIL-13Ralpha2. High-dose treatment combined with stem cell transplantation has been effective in treating HIV-negative lymphoma that has progressed to high-risk or relapsed disease...
2024: Critical Reviews in Immunology
https://read.qxmd.com/read/38617466/very-low-frequency-of-pathological-findings-in-one-year-protocol-biopsies-of-uneventful-standard-risk-kidney-transplant-recipients-results-from-the-nordic-protocol-biopsy-study
#37
JOURNAL ARTICLE
Ilkka Helanterä, Christina Dörje, Fernanda Ortiz, Anna Varberg Reisæter, Clara Hammarström, Jouni Lauronen, Anne Räisänen-Sokolowski, Anders Johan Haugen, Marko Lempinen, Anders Åsberg, Geir Mjøen
BACKGROUND: The clinical significance of kidney transplant protocol biopsies has been debated. We studied the frequency of borderline changes and T cell-mediated rejection (TCMR) in 1-y protocol biopsies in standard risk kidney transplant recipients. METHODS: Consecutive non-HLA-sensitized recipients of kidney transplants between 2006 and 2017, who underwent a protocol biopsy at 1 y in 2 national transplant centers were studied retrospectively (N = 1546)...
May 2024: Transplantation Direct
https://read.qxmd.com/read/38616569/kidney-after-liver-transplantation-does-not-have-an-increased-risk-of-rejection-compared-to-liver-alone
#38
JOURNAL ARTICLE
Peter Ghali, Ramez M Ibrahim, David Hodge, Launia White, Hani M Wadei
BACKGROUND: Simultaneous liver kidney (SLK) transplant protects against acute cellular rejection. In 2017, UNOS implemented a "safety net" policy to allow patients with renal recovery to avoid renal transplantation. Whether kidney after liver transplantation (KALT) increases the risk of rejection is unknown. METHODS: We performed a retrospective analysis of the Organ Procurement and Transplantation Network (OPTN) database of adult patients who received liver transplant, SLK or KALT between 2010 and 2020...
April 2024: Clinical Transplantation
https://read.qxmd.com/read/38616015/mesenchymal-stem-cell-transplantation-may-be-able-to-induce-immunological-tolerance-in-systemic-lupus-erythematosus
#39
JOURNAL ARTICLE
Julia Barbado
Systemic lupus erythematosus (SLE) is a common, potentially fatal autoimmune disease involving a significant inflammatory response. SLE is characterised by failure of self-tolerance and activation of autoreactive lymphocytes, leading to persistent disease. Although current treatments achieve some improvement in patients, some SLE patients are refractory and others relapse after drug withdrawal. The toxicity of current drug regimens, with recurrent infections, together with ongoing inflammation, contribute significantly to the progressive decline in organ function...
April 12, 2024: Biomedical Journal
https://read.qxmd.com/read/38615378/combination-of-chidamide-and-pd-1-blockade-in-refractory-relapsed-aggressive-large-b-cell-lymphomas-with-high-risk-of-failing-car-t-therapy
#40
JOURNAL ARTICLE
Zhenhao Wang, Hao Xu, Yu Mei, Min Xiao, Yang Cao, Liang Huang, Zhuming Yang, Yicheng Zhang, Zhiqiang Han, Miao Zheng, Zhenya Hong
BACKGROUND: Refractoriness and relapse after chimeric antigen receptor T-cell therapy have emerged as major challenges for immunotherapy of aggressive large B-cell lymphoma. Thus far, there is no consensus on how to address treatment failure and whether to administer maintenance therapy following CAR-T cell therapy. METHODS: From August 2017 through November 2022, 52 patients with refractory/relapsed aggressive LBCL who had a high risk of resistance to CAR-T cell therapy were given chidamide in combination with a PD-1 inhibitor as maintenance therapy following either CAR19/22 T-cell cocktail therapy or CAR19/22 T-cell cocktail therapy plus autologous stem cell transplantation (ASCT)...
April 13, 2024: International Immunopharmacology
keyword
keyword
81421
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.